Problem: Human β-defensins (HBDs) are antimicrobial peptides that participate in the soluble innate immune mechanisms against infection. Herein, we determined whether HBD-1 was present in amniotic fluid during normal pregnancy and whether its concentrations change with intra-amniotic inflammation and/or infection.
| INTRODUC TI ON
The amniotic fluid and placenta have antimicrobial properties and function as an immunological barrier to the growing fetus. [1] [2] [3] [4] [5] [6] [7] [8] [9] Specifically, the amniotic fluid contains soluble components such as electrolytes, carbohydrates, lipids, and peptides which can act as a defense against pathogens invading the amniotic cavity. The amniotic fluid also includes cellular components [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] that have been recently characterized using immunophenotyping. 46 It is now clear that amniotic fluid contains both innate and adaptive immune cells such as monocytes/macrophages, neutrophils, innate lymphoid cells, B cells, natural killer cells, and T cells. 46 Most of these immune cells are more abundant in women with intra-amniotic infection and/or inflammation. 46 Among innate immune cells, neutrophils are considered a marker of intra-amniotic inflammation as their number is increased in women with intra-amniotic infection. 47, 48 While amniotic fluid neutrophils are mostly of fetal origin in preterm gestations, they can also be of maternal origin at term. 49 Regardless of their origin, amniotic fluid neutrophils participate in the host defense mechanisms against intra-amniotic infection by performing phagocytosis, 50 forming neutrophil extracellular traps or NETs, 51 and releasing inflammatory mediators 48, including an array of antimicrobial peptides.
18,79-84
Antimicrobial peptides represent soluble mediators of the innate immune system, which provide protection against pathogens. [85] [86] [87] [88] [89] [90] [91] Several families of antimicrobial peptides have been described in mammals, such as cathelicidins and defensins. 92, 93 The latter are small cationic peptides synthesized by neutrophils, Paneth cells, and epithelial cells 85, [94] [95] [96] [97] [98] [99] and are regulated primarily by microbial signals and cytokines, and in some cases by neuroendocrine signals in a tissue-specific manner. 90, 95, 100 Defensins can be of different types based on their function and location of expression in the human body. 90 Two main types of defensins have been identified in humans: α-and β-defensins. 101, 102 Alpha defensins are seen in azurophilic granules in neutrophils 85, 94, 103, 104 and have also been identified in the Paneth cells of intestinal crypts. 95, 98, 105, 106 These mediators have six subtypes referred to as human neutrophil peptide (HNP)-1 to HNP-4 and human defensin-5 and human defensin-6. 90 Increased concentrations of HNP-1 in amniotic fluid have been associated with intrauterine infection and acute histologic chorioamnionitis.
107,108
Human β-defensins (HBD) are expressed in the epithelial cells of mucosal surfaces. 86, 99, 109 HBD-1, HBD-2, and HBD-3 proteins have all been localized in the reproductive tissues including the amnion epithelium, chorion trophoblast, decidua, and placental syncytiotrophoblast. 110 HBD-2 has also been detected in amniotic fluid, and its concentration is increased in women with intra-amniotic inflammation/infection who underwent spontaneous preterm labor with intact membranes and in those with preterm prelabor rupture of membranes (pPROM). 84 However, whether HBD-1 can be detected in amniotic fluid during normal pregnancy and its complications is unknown.
The aims of this study were to (a) detect HBD-1 in amniotic fluid of women in midgestation and at term with or without labor; (b) investigate whether HBD-1 was increased in amniotic fluid of women who underwent spontaneous preterm labor with intact membranes and intra-amniotic inflammation and/or infection; and (c) determine whether HBD-1 concentrations were different between women who underwent pPROM with or without intra-amniotic inflammation/infection.
| MATERIAL S AND ME THODS

| Study design and population
This was a cross-sectional study that was conducted by evaluating our clinical database and bank of biological samples. and without (n = 17) spontaneous labor (Table 1) Table 2 ). Lastly, Group 4 consisted of amniotic fluid samples from women who underwent pPROM with (n = 19) and without (n = 17) intra-amniotic inflammation and infection ( Table 3 ).
The inclusion criteria for uncomplicated pregnancies were as follows: (a) no medical, obstetrical, or surgical complications, (b) absence of microbial invasion of the amniotic cavity (MIAC; see diagnostic criteria below), (c) amniotic fluid IL-6 concentrations <2.6 ng/ mL, (d) intact membranes, and (e) delivery of a term neonate with birthweight appropriate for gestational age.
| Clinical definitions
Spontaneous preterm labor was defined as regular uterine contrac- glucose concentration, 143 Gram stain, 144 and IL-6 concentration. 
| Sample collection
| Determination of IL-6 in amniotic fluid
Amniotic fluid concentrations of IL-6 were determined using a sensitive and specific enzyme immunoassay obtained from R&D systems (Minneapolis, MN, USA). The IL-6 concentrations were determined by interpolation from the standard curves. The inter-and intra-assay coefficients of variation for IL-6 were 8.7% and 4.6%, respectively.
The detection limit of the IL-6 assay was 0.09 pg/mL. The IL-6 concentrations in amniotic fluid were determined for clinical purposes.
| Detection of HBD-1 by ELISA
HBD-1 was detected in amniotic fluid using the Total Beta Defensin 1 ELISA Kit from Aviscera Bioscience (Cat#SK00858-06, Santa Clara, CA, USA). This ELISA kit was validated in our laboratory prior to execution of the study. Amniotic fluid concentrations of HBD-1 were obtained by interpolation from the standard curve. The interand intra-assay coefficients of variation were 14.56% and 11.47%, respectively. The sensitivity of the assay was 8.96 pg/mL.
| Statistical analysis
Statistical analysis was performed using the SPSS v19 software (SPSS Inc., IBM Corporation, Armonk, NY, USA). Normality of the data was tested using the Shapiro-Wilk test. Nonparametric testing was applied for comparisons, and adjustments for multiple comparisons were performed when indicated. Comparisons of the proportions were made using Fisher's exact tests. A P-value of <0.05 was used to determine statistical significance.
| RE SULTS
The demographic and clinical characteristics of the study populations are displayed in Tables 1-3 . Nulliparity rate was similar among the study groups. The maternal age and race were significantly different between women in the midtrimester group and those at term with or without labor (Table 1) , but did not differ among the preterm labor or pPROM groups (Tables 2 and 3 ). The neonatal birthweights were significantly different among the preterm labor groups (Table 2 ) and pPROM groups (Table 3) . Amniotic fluid IL-6 concentrations were elevated in women with spontaneous labor at term compared to those who delivered at term without labor (Table 1) and, as expected, were increased in women with intra-amniotic inflammation and/or infection compared to those without this clinical condition (Tables 2 and   3 ). HBD-1 was detected in all 219 amniotic fluid samples.
| Amniotic fluid HBD-1 concentration in normal pregnancy
The concentration of HBD-1 in amniotic fluid was higher in the midtrimester group than in the term no labor group [midtrimester: 
| Amniotic fluid HBD-1 concentration in women with spontaneous preterm labor
Among women who presented with spontaneous preterm labor, the median amniotic fluid concentration of HBD-1 was higher in women without spontaneous labor at term; (d) among patients with spontaneous preterm labor, amniotic fluid concentrations of HBD-1 were greater in women with intra-amniotic inflammation and infection than in those without intra-amniotic inflammation or infection who delivered preterm or at term; (e) amniotic fluid concentrations of HBD-1 were also higher in women with intra-amniotic inflammation but without infection than in those without intra-amniotic inflammation or infection who delivered preterm or at term; and (f) the presence of intra-amniotic inflammation and infection in patients with pPROM did not change amniotic fluid concentrations of HBD-1.
| D ISCUSS I ON
| The principal findings of this study were as follows
| HBD-1 is present in amniotic fluid and its concentration changes with gestational age
HBD-1 was present in amniotic fluid of women with normal pregnancy. Consistently, previous studies have shown that other human defensins (HBD-2 and HBD-3) are present in the second trimester amniotic fluid. 84, 145 Given that fetal tissues including the lungs, placenta, and chorioamniotic membranes, as well as the decidua express human defensins, 9, 110, [146] [147] [148] [149] [150] it is likely that both fetal and maternal tissues serve as a source for these natural antimicrobial peptides.
The amniotic fluid concentration of HBD-1 was elevated in midtrimester compared to women who delivered at term without labor and in those who delivered at term with labor (comparison not shown), suggesting that this antimicrobial peptide is more required in the second trimester than at term pregnancy. This is in line with the evidence showing that in midtrimester, most of the innate immune cells that participate in host defense mechanisms against infection (e.g, neutrophils) are low in number. 46 Therefore, amniotic fluid HBD-1 may serve as an innate soluble component that protects the fetus against invading pathogens during midtrimester when neutrophils are rare. As gestation progresses toward term, the number of neutrophils in amniotic fluid increases until these immune cells become the dominant leukocyte subset 46 and may take over the host defense mechanisms in the amniotic cavity through performing phagocytosis 50 and NET formation, 51 as well as releasing other antimicrobial peptides. 18, [79] [80] [81] [82] [83] [84] These data indicate that HBD-1 is a physiological component of amniotic fluid during normal pregnancy and that it may be implicated in the soluble innate immune mechanisms which occur in the amniotic cavity early in gestation. 
| Amniotic fluid HBD-1 concentrations do not differ between women with and without spontaneous labor at term
The amniotic fluid concentration of HBD-1 was similar between women with and without spontaneous labor at term. Labor is considered a state of physiologic inflammation [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] as intra-amniotic infection is absent in most women who deliver at term. 117 Therefore, spontaneous labor at term is a sterile inflammatory process and may not need to be associated with an increase in the concentration of HBD-1. This is supported by a previous report showing that the expression of HBD-1 is unchanged in the placenta and chorioamniotic membranes by the process of labor at term. 110 These data show that amniotic fluid HBD-1 is unchanged by the physiological process of labor at term.
| Amniotic fluid HBD-1 concentration is increased in women with spontaneous preterm labor and intra-amniotic inflammation and/ or infection
Women with spontaneous preterm labor and intra-amniotic inflammation and infection (amniotic fluid IL-6 ≥2.6 ng/mL and a positive microbial culture) had higher amniotic fluid concentrations of HBD-1 than those without intra-amniotic inflammation or infection (amniotic fluid IL-6 <2.6 ng/mL and a negative microbial culture) and those who delivered at term. These findings are consistent with a previous report demonstrating that amniotic fluid concentration of HBD-2 is increased in women with MIAC and inflammation. 84 The data presented herein are also consistent with in vitro studies indicating that Candida albicans can increase the release of HBD-1 by the chorioamniotic membranes. 168 The intraamniotic inflammatory process associated with elevated amniotic fluid concentrations of HBD-1 may be mediated by toll-like receptors (TLRs) such as TLR-4 and TLR-2, which had been implicated in the mechanisms that lead to secretion of defensins by epithelial cells. 169 Our data, along with previous studies demonstrating that MIAC results in an increased concentration of lactoferrin, 81, 82 lysozyme, 19, 21 and bacterial/permeability-increasing protein 20 in amniotic fluid and other compartments, 107, [170] [171] [172] suggest that antimicrobial peptides participate in the soluble host defense mechanisms against intra-amniotic infection 173, 174 in women with spontaneous preterm labor and birth.
Women with spontaneous preterm labor with intra-amniotic inflammation but without infection (amniotic fluid IL-6 ≥2.6 ng/mL but a negative microbial culture) had higher amniotic fluid concentrations of HBD-1 than those without intra-amniotic inflammation or infection (amniotic fluid IL-6 <2.6 ng/mL and a negative microbial culture) and those who delivered at term. Given that molecular microbiological detection of nonculturable microbes was not attainable in this study, we cannot discard the possibility that this intra-amniotic inflammatory process is sterile in nature. In the case that nonculturable microbes are present in the amniotic cavity, the resulting intra-amniotic inflammatory response seems to be milder than in cases with culturable microorganisms, suggesting that MIAC potentiates the host response in the amniotic cavity.
In patients with preterm labor, intra-amniotic inflammation can also occur in the absence of microbes detected by cultivation and molecular microbiological techniques (i.e, sterile intra-amniotic inflammation). 126, 128 We and others have proposed that this sterile inflammatory process can be induced by danger signals derived by the fetal tissues. [175] [176] [177] [178] [179] The importance of sterile intra-amniotic inflammation is underscored by the observation that women with such a clinical condition have a similar rate of preterm birth and adverse neonatal outcomes as those with proven intra-amniotic infection. 128 In addition, both sterile intra-amniotic inflammation and intra-amniotic infection are associated with acute histologic chorioamnionitis and funisitis (i.e, acute histologic lesions of the placenta) 128 and high concentrations of inflammatory cytokines in the amniotic cavity. 76 In line with these findings, our data showed that both women with intra-amniotic inflammation/infection and those with intra-amniotic inflammation but without infection have high amniotic fluid concentrations of HBD-1. Collectively, these data suggest that HBD-1 participates in the host response against nonculturable microbes or danger signals in the amniotic cavity. showed that amniotic fluid concentrations of HBD-2 are higher in patients with pPROM and MIAC than in those without MIAC.
84
These findings are explained by evidence indicating that HBD-1 and HBD-2 show differential expression in inflammatory diseases (e.g, periodontitis 180 ) and in human peripheral blood cells stimulated with microbial products. 181 Alternatively, patients with pPROM usually received antibiotic treatment, 182, 183 which could directly reduce the release of antimicrobial peptides and neutrophil-mediated antimicrobial activity, in addition to decreasing the microbial burden. 184, 185 Further research is required to investigate whether antibiotics given to women with pPROM can directly inhibit the secretion of HBD-1 in the presence of bacteria associated with this clinical condition.
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